Exosomal mediated signal transduction through artificial microRNA (amiRNA): A potential target for inhibition of SARS-CoV-2

• Main Authors: Aljabali, A.A.A (Author), Chellappan, D.K (Author), Chen, R.-M (Author), Dua, K. (Author), El-Tanani, M. (Author), Gupta, G. (Author), Kamalakannan, S. (Author), Krishnan, A. (Author), Mishra, V. (Author), Serrano-Aroca, Á (Author), Shitut, A. (Author), Singh, S.K (Author), Tambuwala, M.M (Author), Vadivalagan, C. (Author)
• Format: Article
• Language: English
• Published: Elsevier Inc. 2022
• Subjects: Artificial miRNA; COVID19 mutant; Exosomes; Inhibition; Transcription
• Online Access: View Fulltext in Publisher
• ISBN: 08986568 (ISSN)
• DOI: 10.1016/j.cellsig.2022.110334

Exosome trans-membrane signals provide cellular communication between the cells through transport and/or receiving the signal by molecule, change the functional metabolism, and stimulate and/or inhibit receptor signal complexes. COVID19 genetic transformations are varied in different geographic positions, and single nucleotide polymorphic lineages were reported in the second waves due to the fast mutational rate and adaptation. Several vaccines were developed and in treatment practice, but effective control has yet to reach in cent presence. It was initially a narrow immune-modulating protein target. Controlling these diverse viral strains may inhibit their transuding mechanisms primarily to target RNA genes responsible for COVID19 transcription. Exosomal miRNAs are the main sources of transmembrane signals, and trans-located miRNAs can directly target COVID19 mRNA transcription. This review discussed targeted viral transcription by delivering the artificial miRNA (amiRNA) mediated exosomes in the infected cells and significant resources of exosome and their efficacy. © 2022 The Authors